Pregnancy and cancer is a complex situation. The coincidence of chronic myelogeneous leukemia (CML) and pregnancy is an uncommon event, in part because CML occurs mostly in older age groups. The management of CML during pregnancy is a difficult problem because of the potential effects of the therapy on the mother and fetus. Imatinib is a relatively new drug in this era and it induces dramatic hematologic and cytogenetic responses in CML but it is not recommended for use during pregnancy or if the patient plans to conceive. In the literature there are very few reports of outcome of pregnancy conceived while on imatinib. In this report, we describe a successful pregnancy and labor under treatment of imatinib in a patient who was diagnosed with CML at the beginning of her pregnancy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00404-007-0547-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of the effect of rozanolixizumab on pregnancy outcomes and pre- and postnatal development in cynomolgus monkeys.
Reprod Toxicol
December 2024
Labcorp, Münster, Germany.
Rozanolixizumab, a humanised immunoglobulin (Ig) G4 monoclonal antibody that selectively inhibits binding of IgG to the neonatal Fc receptor (FcRn), was evaluated in an embryo-foetal enhanced pre- and postnatal development (ePPND) study. Pregnant female cynomolgus monkeys (19 per group) received subcutaneous rozanolixizumab 50 mg/kg or 150 mg/kg or vehicle every 3 days from gestation day 20 until delivery. The proportion of pregnancy losses was 15.
View Article and Find Full Text PDFEnhanced Prenatal and Postnatal Development Study in Marmoset Monkeys Following Administration of Felzartamab.
Int J Toxicol
December 2024
Human Immunology Biosciences, Inc., South San Francisco, CA, USA.
Felzartamab is a recombinant fully human immunoglobulin G1 anti-CD38 monoclonal antibody under clinical investigation for immune-mediated diseases. In support of felzartamab clinical development, toxicology studies were conducted in marmoset monkeys, which was the most relevant species based on CD38 binding affinity, pharmacologic activity, and target expression. The felzartamab toxicology program included an enhanced prenatal and postnatal development (ePPND) study to identify potential reproductive and postnatal development risks.
View Article and Find Full Text PDFMethylation Patterns of Diabetes and Obesity Susceptibility Genes in Gestational Diabetes Mellitus: A Cross-Sectional Analysis from Karachi, Pakistan.
Metab Syndr Relat Disord
November 2024
Department of Obstetrics and Gynecology, Aga Khan University, Karachi, Pakistan.
Women with gestational diabetes mellitus (GDM) and their offspring have an increased risk of adverse perinatal and long-term health outcomes, which may be attributable to epigenetic modification of diabetes and obesity susceptibility genes. We aimed to investigate the methylation patterns of eight genes in GDM and normoglycemic (NG) mothers, and their respective offspring. This cross-sectional study, conducted at Aga Khan University from August 2019 to December 2022, recruited pregnant women in the first trimester of gestation from the outpatient obstetrics clinic.
View Article and Find Full Text PDFOutcomes of pregnancy in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
Cancer
January 2025
Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka, Japan.
Article Synopsis
- * A nationwide survey tracked data from 70 pregnancies in 49 CML patients between 2002 and 2020, highlighting three pregnancy types: CML onset during pregnancy, unplanned pregnancies during TKI treatment, and planned pregnancies during treatment-free remission (TFR) or using interferon-alpha (IFN-α).
- * The study found that planned pregnancies had a longer time from CML diagnosis compared to unplanned ones, and TFR or IFN-α were deemed safe pregnancy options—indicating the need for careful planning for pregnancies in women
Maternal and Foetal Outcomes of Newly Diagnosed Chronic Myeloid Leukemia During Pregnancy and its Long-Term Impact.
Indian J Hematol Blood Transfus
October 2024
Department of Clinical Haematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012 India.
Article Synopsis
- Diagnosing Chronic Myeloid Leukemia (CML) during pregnancy poses significant challenges, especially in low- and middle-income countries, with limited management data available.
- The study investigated outcomes for female patients diagnosed with CML-CP during pregnancy, analyzing medical records from 2002 to 2022, highlighting various pregnancy outcomes and treatment strategies.
- Among the thirteen patients examined, outcomes included five elective terminations, five pre-term deliveries, and three full-term deliveries, with a median follow-up showing that most maintained major molecular remission, illustrating the need for coordinated care between haematologists and obstetricians.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!